RERCX
Price
$59.22
Change
-$0.68 (-1.14%)
Updated
Jul 24 closing price
Net Assets
140.66B
WCMIX
Price
$27.68
Change
-$0.13 (-0.47%)
Updated
Jul 24 closing price
Net Assets
21.68B
Interact to see
Advertisement

RERCX vs WCMIX

RERCX vs WCMIX Comparison Chart in %
View a ticker or compare two or three
VS
RERCX vs. WCMIX commentary
Jul 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RERCX is a Hold and WCMIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERCX has more cash in the bank: 141B vs. WCMIX (21.7B). RERCX pays higher dividends than WCMIX: RERCX (2.43) vs WCMIX (0.71). RERCX was incepted earlier than WCMIX: RERCX (24 years) vs WCMIX (15 years). RERCX (1.12) is less costly to investors than WCMIX (1.05). RERCX is a more actively managed with annual turnover of: 50.00 vs. WCMIX (23.00). RERCX has a lower initial minimum investment than WCMIX: RERCX (250) vs WCMIX (100000). WCMIX annual gain was more profitable for investors over the last year : 4.58 vs. RERCX (1.62). WCMIX return over 5 years is better than : 0.12 vs. RERCX (-8.37).
RERCXWCMIXRERCX / WCMIX
Total Expense Ratio1.121.05107%
Annual Report Gross Expense Ratio1.121.05107%
Fund Existence24 years15 years-
Gain YTD1.31711.77711%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets141B21.7B650%
Annual Yield % from dividends2.430.71341%
Returns for 1 year1.624.5835%
Returns for 3 years14.4924.2960%
Returns for 5 years-8.370.12-7,244%
Returns for 10 years40.27117.4834%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EQNTX25.600.11
+0.43%
MFS Equity Income R3
FCADX60.49N/A
N/A
Fidelity Advisor International Discv C
IGFAX5.39N/A
N/A
VY® Morgan Stanley Global Franchise A
OBSIX39.15N/A
N/A
Oberweis Small-Cap Opportunities Instl
BRSTX16.69-0.01
-0.06%
MFS Blended Research Small Cap Eq R3